Pharmacogenetics and Adverse Events in the Use of Fluoropyrimidine in a Cohort of Cancer Patients on Standard of Care Treatment in Zimbabwe

Fluoropyrimidines are commonly used in the treatment of colorectal cancer. They are, however, associated with adverse events (AEs), of which gastrointestinal, myelosuppression and palmar-plantar erythrodysesthesia are the most common. Clinical guidelines are used for fluoropyrimidine dosing based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Afolabi, Boluwatife Lawrence, Mazhindu, Tinashe, Zedias, Chikwambi, Borok, Margaret, Ndlovu, Ntokozo, Masimirembwa, Collen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141018/
https://www.ncbi.nlm.nih.gov/pubmed/37108974
http://dx.doi.org/10.3390/jpm13040588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141018/
https://www.ncbi.nlm.nih.gov/pubmed/37108974
http://dx.doi.org/10.3390/jpm13040588

Ejemplares similares